US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist

1.5800
-0.0200-1.25%

Close Dec 13 16:00 ET

1.5800
0.00000.00%

Post 20:01 ET

103.49MMarket Cap-1.55P/E (TTM)

Regulus Therapeutics Stock Forum

Newbie93

Dec 5 15:24

$Regulus Therapeutics (RGLS.US)$ really ahit stock

Stock_Drift

Oct 24 15:16

After Hours Ticks. 4:15pm

$Visionary Holdings (GV.US)$ $Western Digital (WDC.US)$ $Integrated Media Technology (IMTE.US)$ $Deckers Outdoor (DECK.US)$ $MediaCo (MDIA.US)$ $Skechers USA (SKX.US)$ $Regulus Therapeutics (RGLS.US)$ $Abits (ABTS.US)$ $Spark I Acquisition Corporation (SPKL.US)$ $Tapestry (TPR.US)$ $Antelope Enterprise (AEHL.US)$ $Jeffs' Brands (JFBR.US)$ $Lyell Immunopharma (LYEL.US)$ $Smart Powerr (CREG.US)$ $Bionomics (BNOX.US)$
📊⚡️📊

Trytosaveabit

Oct 8 07:03

Update

$Regulus Therapeutics (RGLS.US)$ Regulus Therapeutics Inc: Remain on Track for an End of Phase 1 Meeting With FDA by End of 2024

Jaguar8

Oct 8 07:02

NEWS

$Regulus Therapeutics (RGLS.US)$
Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Dragana

Sep 12 21:46

$Regulus Therapeutics (RGLS.US)$ is ready Almost there.🙌

Ultratech

Sep 12 20:46

$Regulus Therapeutics (RGLS.US)$
Vanguard loaded

Trytosaveabit

Aug 1 17:56

NFA! Because you asked!

So ive been asked by quite a few people that are newer traders! And because of being where we all have been. They are learning charts and where to enter and exit on momentum / day trades. But having a bit of trouble. Again as we all did and at times still do. Most know that because i cant know others risk tolerance. Or the type of trade they are doing? That i do not give buy / sell advice. But i was asked could i give some swing trade ideas, so they could have a chance to ...

Newbie93

Jun 28 10:05

$Regulus Therapeutics (RGLS.US)$ probably going to below 1$

Stock Region

Jun 25 18:14

Therapeutics Company Reports Positive Topline Data From Major Clinical Trial

Positive Topline Data from Regulus Therapeutics' Phase 1b MAD Clinical Trial of RGLS8429 for ADPKD.
Regulus Therapeutics Inc., a biopharmaceutical company listed on Nasdaq under the ticker symbol RGLS, has recently announced positive topline results from the third cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) clinical trial of RGLS8429. This investigational drug is being developed for the treatment of ...